Related StoriesResearchers identify new way to greatly help AML sufferers avoid a relapseTSRI researchers find way to improve leukemia cells into leukemia-killing immune cellsScientists engineer stem cells to better understand mechanisms behind leukemiaOver the past year the Culture has led collaborative efforts with the FDA, Congress, and senior wellness officials in the Administration to resolve not only this shortage, but also shortages greater than 200 other drugs, many of which are used to treat sufferers with hematologic diseases, that have become crucial and life-threatening. This week the Culture delivered a letter of support to Representatives Larry Buscon and John Carney who introduced bipartisan legislation that would provide expedite FDA overview of drugs in shortage, improve conversation within the company and with stakeholders about feasible shortages, and increase Medication Enforcement Administration quotas for medications an issue.Lung malignancy is the leading reason behind cancer death among men and women.
The CRISPR/Cas9 system has turned into a leading method for genome editing rapidly. Faster and more efficient than other methods, the machine is being improved. This entry informs experts on the latest advancements and highlight the potential of the evolving technology. Combining the latest info on CRISPR/Cas9, the piece links to resources that cover the countless advantages over other strategies such as zinc-finger nucleases and TALENs. By significantly increasing the performance of both transfection and gene editing, the Church Laboratory method alleviates common problems encountered with regular CRISPR/Cas9 protocols. Related StoriesUtah chemists devise fresh way to detect DNA damageNew research examines previously unknown key to DNA repairImproved gene therapy treatment displays promise in mice with cystic fibrosisIn addition to genome editing, the uses of CRISPR have now been expanded to add gene regulation and repurposing as a biological sensor.